This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Corneal Disorders  • Glaucoma  • Alert me on articles by topic

Liang Xu, MD; Haitao Zhang, MD; Ya Xing Wang, MD; Jost B. Jonas, MD

Arch Ophthalmol. 2008;126(3):435-436.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Central corneal thickness (CCT) has been described to be a predictor for the development of primary open-angle glaucoma and the progression of glaucomatous visual field defects in the Ocular Hypertension Treatment Study¹ and other investigations.^2-3 Correspondingly, a previous investigation by Herndon and colleagues³ found that CCT was the most consistent predictor of the degree of glaucomatous damage in their hospital-based cross-sectional study. However, CCT also influences applanation tonometry, so it has remained unclear whether the reported findings are due to the dependence of intraocular pressure measurements on CCT and a corresponding selection artifact of patients or whether a thin cornea may predispose the eye to a higher glaucoma susceptibility. Since optic disc hemorrhages can indicate progression of glaucomatous optic neuropathy and because most of the previous investigations were hospital-based studies with a possible referral bias, it . . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION

RELATED ARTICLES

Central Corneal Thickness as a Risk Factor for Advanced Glaucoma Damage
Leon W. Herndon, Jennifer S. Weizer, and Sandra S. Stinnett
Arch Ophthalmol. 2004;122(1):17-21.
ABSTRACT | FULL TEXT  

Factors for Glaucoma Progression and the Effect of Treatment: The Early Manifest Glaucoma Trial
M. Cristina Leske, Anders Heijl, Mohamed Hussein, Bo Bengtsson, Leslie Hyman, Eugene Komaroff, and for the Early Manifest Glaucoma Trial Group
Arch Ophthalmol. 2003;121(1):48-56.
ABSTRACT | FULL TEXT  

The Ocular Hypertension Treatment Study: Baseline Factors That Predict the Onset of Primary Open-Angle Glaucoma
Mae O. Gordon, Julia A. Beiser, James D. Brandt, Dale K. Heuer, Eve J. Higginbotham, Chris A. Johnson, John L. Keltner, J. Philip Miller, Richard K. Parrish II, M. Roy Wilson, Michael A. Kass, and for the Ocular Hypertension Treatment Study Group
Arch Ophthalmol. 2002;120(6):714-720.
ABSTRACT | FULL TEXT